Articles

Bayer HealthCare’s Mark 7 Arterion angiographic contrast injector

There have been several recent advances with contrast media injector technology, including cutting costs by reducing contrast waste and automated data collection for the dose a patient receives....

Bayer Healthcare, Gadavist, FDA, approval, pediatric patients, contrast media

Bayer HealthCare announced that the U.S. Food and Drug Administration (FDA) has approved Gadavist (gadobutrol) injection for use with magnetic resonance imaging (MRI) in pediatric patients...

Data from a Bayer study in children less than 2 years of age (infants) was presented at the 2014 Radiological Society of North America (RSNA) scientific assembly and annual meeting....

September 10, 2014 — According to new research performed at the Mayo Clinic, iodine-based contrast material injected intravenously to enhance computed tomography (CT) images can be safely used in...

Imaging experts from the American Society of Echocardiography (ASE) released a paper, "Guidelines for the Cardiac Sonographer in the Performance of Contrast Echocardiography: A Focused Update from...

The American Society of Echocardiography Foundation (ASEF) launched the second version of its free mobile Echo AUC app at the ASE Silver Anniversary Scientific Sessions in Portland, Ore., last...

Iodixanol Iopamidol Contrast Media Peripheral Arteriography ACC.14 Clinical Stud

GE Healthcare announced results from a new clinical study, which showed that patients receiving iodixanol (Visipaque) 320mg I/ml reported less discomfort, characterized by heat or cold sensation...

Guerbet FlowSens Contrast Media Injectors CT Systems X-Ray

Guerbet announced a worldwide launch of FlowSens, a contrast agent injection solution used in...

mri systems contrast media diamonds nanodiamonds cambridge

Researchers say they have achieved enough coherence of the magnetic moment inherent in the defects of miniscule diamond fragments to harness their potential for precise quantum sensors in a...

No law prevents doctors from freely prescribing U.S. Food and Drug Administration (FDA)-approved drugs and devices for off-label uses, yet regulators continue to aggressively pursue civil and...